Salud financiera de hoja de balance de Austar Lifesciences
Salud financiera controles de criterios 3/6
Austar Lifesciences tiene un patrimonio de los accionistas total de CN¥775.5M y una deuda total de CN¥430.7M, lo que sitúa su ratio deuda-patrimonio en 55.5%. Sus activos y pasivos totales son CN¥2.2B y CN¥1.4B respectivamente.
Información clave
49.5%
Ratio deuda-patrimonio
CN¥386.27m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | CN¥139.98m |
| Patrimonio | CN¥780.63m |
| Total pasivo | CN¥1.36b |
| Activos totales | CN¥2.14b |
Actualizaciones recientes sobre salud financiera
Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28
We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Recent updates
Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥1.6B) de 6118 superan a sus pasivos a corto plazo (CN¥1.2B).
Pasivo a largo plazo: Los activos a corto plazo de 6118 (CN¥1.6B) superan a sus pasivos a largo plazo (CN¥205.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (33.1%) de 6118 se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de 6118 ha crecido de 5.4% a 55.5% en los últimos 5 años.
Cobertura de la deuda: La deuda de 6118 no está bien cubierta por el flujo de caja operativo (5.6%).
Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de 6118 sobre su deuda están bien cubiertos por el EBIT.